MK-677 Protocol
Dosing & Research
Last Updated: April 22, 2026
GH/IGF-1 axis studies, Sleep and recovery research, Appetite signaling, Body-composition research
Half-Life
Approximately 24 Hours
Administration
Oral
Frequency
1x Daily
How It Works
- GH/IGF-1 axis studies
- Sleep and recovery research
- Appetite signaling
- Body-composition research
Dosing Structure
Dose
5–25mg oral daily
Frequency
1x Daily
Notes
Break: Equal cycle length (8-12 weeks minimum). Research shows up to 18 months safety.
Example Protocols
Dose: 5–25mg oral daily
Frequency: 1x Daily
Duration: 8-12 weeks
Off Period: Not listed
Protocol Notes
•
Break: Equal cycle length (8-12 weeks minimum).
•
Research shows up to 18 months safety.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.